SCPH

scPharmaceuticals
SCPH

Delisted

SCPH was delisted on the 6th of October, 2025.

31 hedge funds and large institutions have $108M invested in scPharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-7
Holders Change %
-18.42%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
12
Reduced
11
Closed
9
Calls
$21K
Puts
Net Calls
+$21K
Net Calls Change
+$3K
Name Holding Trade Value Shares
Change
Shares
Change %
Bank of America
26
Bank of America
North Carolina
$8K -$2.35K -339 -23%
UBS Group
27
UBS Group
Switzerland
$6K +$989 +139 +20%
Barclays
28
Barclays
United Kingdom
$5K +$270 +44 +6%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$1K -$10.1K -795 -91%
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$705 -$1.02K -153 -59%
Russell Investments Group
31
Russell Investments Group
United Kingdom
-$1.19M -194,238 Closed
Goldman Sachs
32
Goldman Sachs
New York
-$704K -115,264 Closed
DCM
33
DAFNA Capital Management
California
-$238K -38,891 Closed
First Trust Advisors
34
First Trust Advisors
Illinois
-$144K -23,614 Closed
Two Sigma Advisers
35
Two Sigma Advisers
New York
-$67K -11,000 Closed
JPMorgan Chase & Co
36
JPMorgan Chase & Co
New York
-$19K -3,174 Closed
TRCT
37
Tower Research Capital (TRC)
New York
-$13K -2,112 Closed